2026 ASH®
Annual Meeting & Exposition December 12-15, 2026 ▪ New Orleans, Louisiana

Begin New Search

Paper Details

Abstracts, authors, affiliations, and disclosures.

SESSION

623. Mantle Cell, Follicular, Waldenstrom’s, and Other Indolent B Cell Lymphomas: Clinical and Epidemiological - From Cytotoxic to Selective: The BTK Inhibitor Revolution in The Frontline Treatment of Mantle Cell Lymphoma

Program: Oral Abstract Session
Monday, December 14, 2026
04:30 p.m. - 06:00 p.m.
MCCNO - New Orleans Theatre B

KEYWORDS

Treatment Considerations, Combination Therapy, Diseases, Lymphoid Malignancies, Lymphomas, Non-Hodgkin Lymphoma, B Cell Lymphoma, Indolent Lymphoma, Aggressive Lymphoma, Research, Clinical Research, Clinical Trials, Study Population, Human, Adult
PAPER

AUTHORS

AFFILIATIONS

ABSTRACT

DISCLOSURES

Begin New Search